Cytokinetics
Erin has been our Vice President of Portfolio and Project Management since September 2019. She has held positions of increasing responsibility in portfolio, program and project management, regulatory affairs and quality assurance since joining Cytokinetics in May 2003. Erin joined Cytokinetics as the first development employee and she has contributed to every drug development program in Cytokinetics history.
Prior to Cytokinetics, Erin was Director, Research & Development Operations at Millennium Pharmaceuticals, where she was responsible for five cardiovascular franchise development programs, and served on the integration team after the company acquired COR Therapeutics in 2002. Previously, Erin served in roles of increasing responsibility at COR Therapeutics between 1991 and 2002, including in project management and regulatory affairs.
This person is not in any offices
Cytokinetics
15 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.